Intrinsic Value of S&P & Nasdaq Contact Us

ICON Public Limited Company ICLR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • IE • USD

SharesGrow Score
71/100
4/7 Pass
SharesGrow Intrinsic Value
$217.20
+92.1%
Analyst Price Target
$157.44
+39.3%

ICON Public Limited Company (ICLR) generated $1.29B in operating cash flow for fiscal year 2024. After capital expenditures of $168.06M, free cash flow was $1.12B.

Free cash flow margin was 13.5% of revenue. Cash conversion ratio was 1.63x, indicating earnings are backed by cash.

The company returned $500M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (49/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (45/100) — Cash conversion ratio was 1.63x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 71/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
71/100
SG Score
View full scorecard →
VALUE
80/100
Price-to-Earnings & upside
→ Valuation
FUTURE
64/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
49/100
Proven by this page
GROWTH
90/100
→ Income
~
INCOME
45/100
→ Income
ICON Public Limited Company Cash Flow History
Metric TTM FY2024 FY2023 FY2022 FY2021
Operating Cash Flow $1.18B$1.29B$1.16B$563.32M$829.14M
Capital Expenditure $-181.46M$-168.06M$-140.69M$-142.16M$-93.75M
Free Cash Flow $995.8M$1.12B$1.02B$421.16M$735.39M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message